Cargando…

CD95/Fas ligand mRNA is toxic to cells through more than one mechanism

CD95/Fas ligand (CD95L) induces apoptosis through protein binding to the CD95 receptor. However, CD95L mRNA also induces toxicity in the absence of CD95 through induction of DISE (Death Induced by Survival Gene Elimination), a form of cell death mediated by RNA interference (RNAi). We now report tha...

Descripción completa

Detalles Bibliográficos
Autores principales: Haluck-Kangas, Ashley, Fink, Madelaine, Bartom, Elizabeth T., Peter, Marcus E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Nature Singapore 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10105004/
https://www.ncbi.nlm.nih.gov/pubmed/37059938
http://dx.doi.org/10.1186/s43556-023-00119-1
_version_ 1785026147027779584
author Haluck-Kangas, Ashley
Fink, Madelaine
Bartom, Elizabeth T.
Peter, Marcus E.
author_facet Haluck-Kangas, Ashley
Fink, Madelaine
Bartom, Elizabeth T.
Peter, Marcus E.
author_sort Haluck-Kangas, Ashley
collection PubMed
description CD95/Fas ligand (CD95L) induces apoptosis through protein binding to the CD95 receptor. However, CD95L mRNA also induces toxicity in the absence of CD95 through induction of DISE (Death Induced by Survival Gene Elimination), a form of cell death mediated by RNA interference (RNAi). We now report that CD95L mRNA processing generates a short (s)RNA nearly identical to shL3, a commercial CD95L-targeting shRNA that led to the discovery of DISE. Neither of the miRNA biogenesis proteins Drosha nor Dicer are required for this processing. Interestingly, CD95L toxicity depends on the core component of the RISC, Ago2, in some cell lines, but not in others. In the HCT116 colon cancer cell line, Ago 1–4 appear to function redundantly in RNAi. In fact, Ago 1/2/3 knockout cells retain sensitivity to CD95L mRNA toxicity. Toxicity was only blocked by mutation of all in-frame start codons in the CD95L ORF. Dying cells exhibited an enrichment of RISC bound (R)-sRNAs with toxic 6mer seed sequences, while expression of the non-toxic CD95L mutant enriched for loading of R-sRNAs with nontoxic 6mer seeds. However, CD95L is not the only source of these R-sRNAs. We find that CD95L mRNA may induce DISE directly and indirectly, and that alternate mechanisms may underlie CD95L mRNA processing and toxicity. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s43556-023-00119-1.
format Online
Article
Text
id pubmed-10105004
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Springer Nature Singapore
record_format MEDLINE/PubMed
spelling pubmed-101050042023-04-16 CD95/Fas ligand mRNA is toxic to cells through more than one mechanism Haluck-Kangas, Ashley Fink, Madelaine Bartom, Elizabeth T. Peter, Marcus E. Mol Biomed Research CD95/Fas ligand (CD95L) induces apoptosis through protein binding to the CD95 receptor. However, CD95L mRNA also induces toxicity in the absence of CD95 through induction of DISE (Death Induced by Survival Gene Elimination), a form of cell death mediated by RNA interference (RNAi). We now report that CD95L mRNA processing generates a short (s)RNA nearly identical to shL3, a commercial CD95L-targeting shRNA that led to the discovery of DISE. Neither of the miRNA biogenesis proteins Drosha nor Dicer are required for this processing. Interestingly, CD95L toxicity depends on the core component of the RISC, Ago2, in some cell lines, but not in others. In the HCT116 colon cancer cell line, Ago 1–4 appear to function redundantly in RNAi. In fact, Ago 1/2/3 knockout cells retain sensitivity to CD95L mRNA toxicity. Toxicity was only blocked by mutation of all in-frame start codons in the CD95L ORF. Dying cells exhibited an enrichment of RISC bound (R)-sRNAs with toxic 6mer seed sequences, while expression of the non-toxic CD95L mutant enriched for loading of R-sRNAs with nontoxic 6mer seeds. However, CD95L is not the only source of these R-sRNAs. We find that CD95L mRNA may induce DISE directly and indirectly, and that alternate mechanisms may underlie CD95L mRNA processing and toxicity. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s43556-023-00119-1. Springer Nature Singapore 2023-04-15 /pmc/articles/PMC10105004/ /pubmed/37059938 http://dx.doi.org/10.1186/s43556-023-00119-1 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Research
Haluck-Kangas, Ashley
Fink, Madelaine
Bartom, Elizabeth T.
Peter, Marcus E.
CD95/Fas ligand mRNA is toxic to cells through more than one mechanism
title CD95/Fas ligand mRNA is toxic to cells through more than one mechanism
title_full CD95/Fas ligand mRNA is toxic to cells through more than one mechanism
title_fullStr CD95/Fas ligand mRNA is toxic to cells through more than one mechanism
title_full_unstemmed CD95/Fas ligand mRNA is toxic to cells through more than one mechanism
title_short CD95/Fas ligand mRNA is toxic to cells through more than one mechanism
title_sort cd95/fas ligand mrna is toxic to cells through more than one mechanism
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10105004/
https://www.ncbi.nlm.nih.gov/pubmed/37059938
http://dx.doi.org/10.1186/s43556-023-00119-1
work_keys_str_mv AT haluckkangasashley cd95fasligandmrnaistoxictocellsthroughmorethanonemechanism
AT finkmadelaine cd95fasligandmrnaistoxictocellsthroughmorethanonemechanism
AT bartomelizabetht cd95fasligandmrnaistoxictocellsthroughmorethanonemechanism
AT petermarcuse cd95fasligandmrnaistoxictocellsthroughmorethanonemechanism